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The p53 tumour suppressor protein inhibits the develop-
ment of cancer by initiating various cellular responses
including apoptosis, senescence and cell cycle arrest. In
addition to this, recent studies have found that p53 is also
able to influence cell metabolism. TP53-induced glycolysis
and apoptosis regulator (TIGAR) was discovered as a p53
target functioning as a fructose-2,6-bisphosphatase. In this
way, TIGAR promotes the diversion of glycolytic metabo-
lites to other pathways such as the pentose phosphate
pathway, which allows for NADPH production to protect
cells from oxidative stress as well as providing ribose-5-
phosphate for nucleotide synthesis.
While discovered as a p53 target, comparison between
human and mouse TIGAR suggests that mouse TIGAR
is not as greatly induced by p53. In mouse intestines,
TIGAR is important in repair following tissue injury and
mice that are TIGAR-deficient show elevated levels of
oxidative stress following damage. As the Wnt/Myc sig-
nalling pathway is important in cellular proliferation and
tissue regeneration, its potential role in regulating
TIGAR was investigated. Deletion of APC in mouse
intestines, leading to high Wnt pathway activation,
results in an increased expression of TIGAR, which is
reduced when Myc is also lost, suggesting that the Wnt/
Myc signalling pathway may influence the regulation of
TIGAR.
Together, the results suggest that TIGAR can be regu-
lated through p53-dependent and independent mechan-
isms to contribute to the control of tissue regeneration
and tumorigenesis.
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